title: Astrocyte-enriched miR-29a targets PUMA and reduces neuronal vulnerability to forebrain ischemia.
abstract: Following transient forebrain ischemia, astrocytes play a key role in determining whether or not neurons in the hippocampal CA1 sector go on to die in a delayed fashion. MicroRNAs (miRNAs) are a novel class of RNAs that control gene expression at the post-transcriptional level and the miR-29 family is highly expressed in astrocytes. In this study we assessed levels of miR-29 in hippocampus following forebrain ischemia and found that after transient forebrain ischemia and short periods of reperfusion, miR-29a significantly increased in the resistant dentate gyrus, but decreased in the vulnerable CA1 region of the hippocampus. We demonstrate that miR-29a targets BH3-only proapoptotic BCL2 family member PUMA by luciferase reporter assay and by Western blot. Comparing primary neuron and astrocyte cultures, and postnatal brain, we verified the strongly astrocytic expression of miR-29a. We further found that miR-29a mimic protects and miR-29a inhibitor aggravates cell injury and mitochondrial function after ischemia-like stresses in vitro. Lastly, by overexpressing and reducing miR-29a we demonstrate the protective effect of miR-29a on CA1 delayed neuronal death after forebrain ischemia. Our data suggest that by targeting a pro-apoptotic BCL2 family member, increasing levels of miR-29a might emerge as a strategy for protection against ischemia-reperfusion injury.
authors.affiliation: Department of Anesthesia, Stanford University School of Medicine, Stanford, California.
authors.forename: Yi-Bing
authors.initials: YB
authors.lastname: Ouyang
authors.forename: Lijun
authors.initials: L
authors.lastname: Xu
authors.forename: Yu
authors.initials: Y
authors.lastname: Lu
authors.forename: Xiaoyun
authors.initials: X
authors.lastname: Sun
authors.forename: Sibiao
authors.initials: S
authors.lastname: Yue
authors.forename: Xiao-Xing
authors.initials: XX
authors.lastname: Xiong
authors.forename: Rona G
authors.initials: RG
authors.lastname: Giffard
mesh_terms: D000818:Animals; D051017:Apoptosis Regulatory Proteins / Q000235:genetics / Q000378:metabolism*; D001253:Astrocytes / Q000378:metabolism*; D016923:Cell Death / Q000502:physiology; D002546:Ischemic Attack, Transient / Q000378:metabolism*; D035683:MicroRNAs / Q000378:metabolism*; D008928:Mitochondria / Q000235:genetics / Q000378:metabolism; D009474:Neurons / Q000378:metabolism*; D016548:Prosencephalon / Q000378:metabolism*; D051381:Rats; D015427:Reperfusion Injury / Q000378:metabolism
chemical_list: D051017:Apoptosis Regulatory Proteins; C533952:Bbc3 protein, rat; C526366:MIRN29 microRNA, rat; D035683:MicroRNAs
keywords: PUMA; astrocyte; microRNA
references.citation: J Neurochem. 2010 Jul;114(2):606-16
references.pmid: 20477911
references.citation: J Neurosci. 1995 Jun;15(6):4545-55
references.pmid: 7540679
references.citation: J Clin Neurosci. 2010 Jun;17(6):774-8
references.pmid: 20080409
references.citation: Curr Drug Targets. 2013 Jan 1;14(1):90-101
references.pmid: 23170800
references.citation: Mitochondrion. 2012 Mar;12(2):213-9
references.pmid: 21958558
references.citation: Cell Death Differ. 2007 Jul;14(7):1324-35
references.pmid: 17431421
references.citation: Proc Natl Acad Sci U S A. 2008 Apr 29;105(17):6415-20
references.pmid: 18434550
references.citation: Genes Dev. 2011 Jan 15;25(2):125-30
references.pmid: 21245165
references.citation: N Engl J Med. 2002 Feb 21;346(8):549-56
references.pmid: 11856793
references.citation: Exp Brain Res. 2012 Jan;216(2):225-30
references.pmid: 22094713
references.citation: Stroke. 2008 Mar;39(3):959-66
references.pmid: 18258830
references.citation: Cancer Cell. 2003 Oct;4(4):321-8
references.pmid: 14585359
references.citation: Mol Cell. 2001 Mar;7(3):673-82
references.pmid: 11463391
references.citation: J Cereb Blood Flow Metab. 2009 Apr;29(4):675-87
references.pmid: 19142192
references.citation: Neurobiol Dis. 2012 Jan;45(1):555-63
references.pmid: 21983159
references.citation: Mitochondrion. 2011 Mar;11(2):279-86
references.pmid: 21047562
references.citation: N Engl J Med. 2002 Feb 21;346(8):557-63
references.pmid: 11856794
references.citation: Neurol Res. 2004 Sep;26(6):632-43
references.pmid: 15327753
references.citation: Nat Rev Neurosci. 2005 Aug;6(8):626-40
references.pmid: 16025096
references.citation: Glia. 2005 Jun;50(4):281-6
references.pmid: 15846807
references.citation: Eur J Neurosci. 2011 Feb;33(3):401-8
references.pmid: 21198986
references.citation: Cell Death Dis. 2010 Jul 29;1:e59
references.pmid: 21364664
references.citation: Cell Mol Biol Lett. 2012 Dec;17(4):646-69
references.pmid: 23001513
references.citation: J Neurosci. 2007 Apr 18;27(16):4253-60
references.pmid: 17442809
references.citation: Glia. 2010 Jul;58(9):1042-9
references.pmid: 20235222
references.citation: J Cereb Blood Flow Metab. 2010 Jan;30(1):92-101
references.pmid: 19724284
references.citation: Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11318-23
references.pmid: 11572983
references.citation: Stroke. 2009 Feb;40(2):618-25
references.pmid: 19095966
references.citation: Oncogene. 2008 Dec;27 Suppl 1:S71-83
references.pmid: 19641508
references.citation: Neuropathol Appl Neurobiol. 2010 Jun;36(4):320-30
references.pmid: 20202123
references.citation: Neurosci Lett. 1989 Aug 28;103(2):162-8
references.pmid: 2570387
references.citation: J Neurochem. 2007 Aug;102(4):1383-94
references.pmid: 17488276
references.citation: Free Radic Biol Med. 2002 Aug 15;33(4):544-51
references.pmid: 12160936
references.citation: Methods. 2001 Dec;25(4):402-8
references.pmid: 11846609
references.citation: J Cereb Blood Flow Metab. 2006 Jul;26(7):937-50
references.pmid: 16292251
references.citation: Mol Cell. 2001 Mar;7(3):683-94
references.pmid: 11463392
references.citation: PLoS One. 2013;8(3):e58039
references.pmid: 23516428
references.citation: Eur J Neurosci. 2005 Mar;21(6):1469-77
references.pmid: 15845075
references.citation: Cell Stress Chaperones. 2006 Summer;11(2):180-6
references.pmid: 16817324